PTX3: Clinical Trials

2 trials of PTX3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Active not recruiting 1

Follow PTX3: new trials by email Literature Review of PTX3 trials Research Report on PTX3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MICROVASCULAR DAMAGE IN THROMBOTIC THROMBOCYTOPENIC PURPURA
Factor VIII (FVIII), Von Willebrand factor (VWF) antigen, VWF:RCo - TTP - Thrombotic Thrombocytopenic Purpura
Not applicableActive not recruitingFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico792026-02-282026-06-09
Association of Plasma PTX3 Concentration and Outcomes of STEMI
Plasma PTX3 concentration - STEMI, Coronary; Ischemic
CompletedIndonesian Cardiovascular Research Center3352018-01-012019-03-28

Conditions studied

Ischemia (1)  ·  Purpura, Thrombotic Thrombocytopenic (1)  ·  ST Elevation Myocardial Infarction (1)

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  Indonesian Cardiovascular Research Center (1)

Countries

Indonesia (1)  ·  Italy (1)